James Longstreth

2PUBLICATIONS
26CO-AUTHORS
Characterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 20, 2023
Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies.

Benedito A Carneiro, Ludimila Cavalcante, Devalingam Mahalingam

Pageof 1